Sepse em pacientes queimados by Macedo, Jefferson Lessa Soares de et al.
647
ARTIGORevista da Sociedade Brasileira de Medicina Tropical
36(6):647-652, nov-dez, 2003.
Sepsis in burned patients
Sepse em pacientes queimados
Jefferson Lessa S. de Macedo1, Simone C. Rosa1
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Abstract  A prospective study was conducted from June 2001 to May 2002 at the Burns Unit of Hospital
Regional da Asa Norte, Brasília, Brazil. During the period of the study, 252 patients were treated at the Burns
Unit, 49 (19.4%) developed clinically and microbiologically proven sepsis. Twenty-six (53.1%) were males and
23 (46.9%) females with a mean age of 22 years (range one to 89 years) and mean burned body surface area of
37.7 ± 18.4% (range 7 to 84%). Forty-three patients had flame burns, five a scald and one an electric burn.
These 49 patients had a total of 62 septic episodes. Forty (81.6%) patients had only one and nine (18.4%) had
up to three episodes of sepsis. Thirty (61.2%) patients had their first septicemic episode either earlier or by one
week postburn. Out of 62 septic episodes, 58 were due to bacteria and four due to Candida sp. The most
common bacteria isolated from blood culture were Staphylococcus aureus, coagulase-negative Staphylococcus,
Acinetobacter baumannii, Enterobacter cloacae and Klebsiella pneumoniae. Eleven (18.9%) episodes were due
to oxacillin resistant Staphylococcus aureus. Acinetobacter baumannii was sensitive to ampicillin/sulbactam in
71.4% and to imipenem in 85.7% of the cases. The primary foci of sepsis were the burn wound in 15 ( 24.2% )
episodes. The most common clinical findings of sepsis in these patients were fever, dyspnea, hypotension and
oliguria. The most common laboratory findings of these patients were anemia, leukocytosis, hypoalbuminemia
and thrombocytopenia. Twelve (24.5%) patients died. The appropriate knowledge of clinical, epidemiological,
laboratorial and microbiological aspects of sepsis in burned patients permits an adequate diagnosis and treatment
of this complication.
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Resumo  Um estudo prospectivo foi realizado de junho de 2001 a maio de 2002, na Unidade de Queimados do
Hospital Regional da Asa Norte, Brasília, Brasil. Durante o período do estudo, 252 pacientes foram tratados na
Unidade de Queimados, 49 (19,4%) desenvolveram sepse clinicamente e microbiologicamente provada. Vinte e
seis (53,1%) eram homens, 23 (46,9%) eram mulheres, com uma média de idade de 22 anos (variação de um
a 89 anos) e superfície corporal queimada total de 37,7 ± 18,4% (variação de 7 a 84 %). Quarenta e três
pacientes tiveram queimaduras por chama aberta, cinco por escaldamento e um por queimadura elétrica. Esses
49 pacientes tiveram um total de 62 episódios septicêmicos. Quarenta (81,6%) pacientes tiveram somente um
episódio de sepse e nove (18,4%) tiveram até três episódios. Trinta (61,2%) pacientes tiveram seu primeiro
episódio septicêmico dentro da primeira semana após a queimadura. Dos 62 episódios de sepse, 58 foram
bacterianos e quatro por Candida sp. As bactérias mais comumente isoladas das hemoculturas foram
Staphylococcus aureus, Staphylococcus coagulase-negativo, Acinetobacter baumannii, Enterobacter cloacae
e Klebsiella pneumoniae. Onze (18,9%) episódios foram devido a S. aureus resistentes à oxacilina. A. baumannii
era sensível a ampicilina/sulbactam em 71,4% e ao imipenem em 85,7% dos casos. O foco primário da sepse
foi a queimadura em 15 (24,2%) episódios. Os achados clínicos mais comuns da sepse foram a febre, dispnéia,
hipotensão e oligúria. As alterações laboratoriais mais comuns foram a anemia, leucocitose, hipoabuminemia e
trombocitopenia. Doze (24,5%) pacientes morreram. O conhecimento apropriado dos aspectos clínicos,
epidemiológicos, laboratoriais e microbiológicos da sepse no paciente queimado favorecem um adequado
diagnóstico e tratamento dessa complicação.
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Despite advances in the use of topical and
parenteral antimicrobial therapy, and the practice of
early tangential excision, sepsis remains a major cause
of death in burn victims today. Few patients are as
susceptible to the development of systemic infections
as burn patients. Severe dysfunction of the immune
system, a large cutaneous colonization, the possibility
of gastrointestinal translocation, a prolonged
hospitalization and invasive diagnostic and therapeutic
procedures, all contribute to sepsis1  2 7 9 19 20 21 30.
The experience accumulated over the past three
decades, in the early interventional treatment of burns
patients has dramatically changed the cause of death;
it is now estimated that about 75 percent of the mortality
following burn injuries is related to infections, rather
than to osmotic shock and hypovolemia. Therefore,
knowledge of the responsible microflora, together with
its prevalence and bacterial resistance, is of crucial
importance for fast and reliable therapeutic decisions.
The present study was undertaken to analyze 49
clinically diagnosed and blood culture positive sepsis
patients who were treated during a one-year period.
The identification of the microorganisms and the
susceptibility of all bacteria isolated were studied.
PATIENTS AND METHODS
Our analysis was based on a prospective study
which was conducted from June 2001 to May 2002 at
the Burns Unit of Hospital Regional da Asa Norte,
Brasília, Brazil.
Since 1980, patients having partial thickness skin
burns covering less than 25 percent of the body surface
area, were not generally admitted to the Burns Unit if they
were adults, or less than 10 per cent if they were children.
Patients with full thickness skin burns of small extent
(≤5% of the body surface area), were also treated as
outpatients until the wound was ready for excision and
grafting by members of plastic surgery team. Commonly
admission to the Burns Unit only occured with severely
burned patients (>25-30% of the body surface area).
All patients who were admitted to the Burns Unit
were resuscitated based on the Parkland formulae
guidelines using crystalloids, except in few cases
where there was either delayed or difficult resuscitation
and colloids were used earlier than 24h postburn15.
Silver sulfadiazine (1% flamazine) was used
topically and the dressings were changed daily. The
wound was inspected daily during dressing and swabs
for culture from the burn wounds were taken weekly or
when an infection was suspected.
Sepsis was suspected when a patient showed signs
of disorientation, hyperthermia or hypothermia,
circulatory embarrassment, hemorrhages, leukocytosis,
thrombocytopenia and/or oliguria. A blood culture was
always done for confirmation and the results of all
microbiological cultures of the burn wound, urine,
tracheal secretion and vascular catheter were
considered.
A set of two blood cultures was taken with an
interval of one hour in patients with clinical sepsis.
Blood samples were not taken through the central
venous catheters, but through another central vein.
The immediate institution of empirical antibiotic therapy
in such cases was done after consultation with the
microbiologist reviewing the previous burn wound swab
cultures. The bacteriological isolation was carried out
in the microbiology laboratory of the Hospital Regional
da Asa Norte, Brasília. The blood specimens were
processed in a Bact Alert 120 and in a MicroScan
96 machine which is known for quick detection of
bacterial growth leading to an early diagnosis.
Repeated specimens were collected if cultures were
negative after 24h. If positive, the microbiologist
immediately contacted the clinician with the Gram stain
results and antibiotic therapy was modified whenever
necessary. The specific isolation of pathogen was made
using a specific culture medium for bacteria (blood
agar for gram positive and MacConkey for gram
negative) or fungus (Sabouraud’s dextrose agar).
The criteria for determining the source of sepsis
were: a) finding of the same pathogen as in the blood
culture in burn wound, urine, tracheal exudates, or
vascular catheter; b) Clinical and bacteriological
evidence of infection: discoloration and odor from the
wounds > 105 organisms/g tissue; urinary tract infection
with 105 cfu/ml urine; respiratory tract infection; catheter-
related infection were defined as those giving >15cfu.
On removal of the vascular or urinary catheter, the distal
tip (about 20mm long) was cut and investigated in the
microbiology laboratory using roll plate method13.
RESULTS
Two hundred and fifty-two cases were treated as in-
patients at the Burns Unit of Hospital Regional da Asa
Norte during the period of the study, 49 (19.4%)
developed clinically and microbiologically proven sepsis
during their stay in the hospital. Twenty-six (53.1%) were
males, 23 (46.9%) females, with a mean age of 22
years (range one to 89 years) and mean total body
surface area burn of 37.7 ± 18.4% (range 7 to 84%).
The flame burn was the predominant cause of burns
amongst patients who had sepsis. Forty-three had flame
burns, five a scald and one had a electric burn. These
49 patients had a total of 62 septic episodes. Forty
(81.6%) had only one and nine (18.4%) had up to three
episodes of sepsis.
Thirty (61.2%) patients had their first septic
episode between 3 – 7 days postburn, 14 (28.6%)
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between 8 – 14 days and five (10.2%) after 15 days
postburn.
Out of the 62 septic episodes, 34 (54.8%) were due to
gram positive, 11 (17.7%) due to gram negative, four (6.5%)
due to fungi and 13 (21%) due to mixed organisms. Out of
the 62 episodes, 58 (93.5%) were due to bacteria and four
(6.5%) due to fungus (Candida sp). The most common
bacteria isolated from blood culture were Staphylococcus
aureus, coagulase-negative Staphylococcus, Acinetobacter
baumannii, Enterobacter cloacae and Klebsiella
pneumoniae. Eleven (18.9%) episodes were due to oxacillin
resistant Staphylococcus aureus (Table 1).
Table 1 - Microbial etiology of 58 bacteraemic episodes of
sepsis in 49 burned patients treated at the Burns Unit of




oxacillin  susceptible 16 27.6
oxacillin resistant 11 18.9
Coagulase-negative
Staphylococci 12 20.7
Acinetobacter baumannii  7 12.1
Enterobacter cloacae 7 12.1
Klebsiella pneumoniae 5 8.6
Pseudomonas aeruginosa 4 6.9
Serratia marcescens 1 1.7
Citrobacter freundii 1 1.7
Providencia rettgeri  1 1.7
E. coli 1 1.7
Enterococcus faecalis 1 1.7
Stenotrophomonas maltophilia 1 1.7
 The source of the 62 septic episodes were burn
wound in 15 (24.2%) episodes, lung in four (6.1%),
vascular catheter in three (4.8%) and the source
remained undetermined in 40 (64.5%) episodes.
Table 2 presents the antimicrobial susceptibility of
the gram-positive bacteria isolated from blood culture of
burned patients with sepsis. The incidence of oxacillin
resistance among staphylococci were high (40.7% for
Staphylococcus aureus and 50% for coagulase-negative
Staphylococcus). The oxacillin resistant Staphylococcus
aureus showed low susceptibility to gentamicin,
ciprofloxacin, co-trimoxazole, clindamycin and imipenem.
However all staphylococci were susceptible to
vancomycin. The oxacillin susceptible Staphylococcus
aureus showed high susceptibility to a wide range of
antibiotics. Coagulase-negative Staphylococcus
showed low to moderate susceptibility to amoxicillin/
clavulanic acid, cephalothin, cefuroxime, imipenem,
oxacillin, gentamicin, amikacin and co-trimazole, but
its susceptibility was high to ciprofloxacin, clindamycin
and vancomycin.
Table 3 presents the antimicrobial susceptibility of
the gram-negative bacteria isolated from blood culture
of burned patients with sepsis. More than 70% of
Acinetobacter baumannii isolated were susceptible only
to ampicillin/sulbactam and imipenem. More than 70%
of E. cloacae and K. pneumoniae were sensitive to
imipenem, gentamicin, amikacin and ciprofloxacin. All
strains of P. aeruginosa were sensitive to imipenem,
amikacin and ciprofloxacin.
The most common clinical findings of sepsis in these
patients were fever, dyspnea, hypotension and oliguria.
On the other hand, the most common laboratory findings
of these patients were anemia, leukocytosis,
hypoalbuminemia and thrombocytopenia (Table 4).
Table 2 - Antimicrobial susceptibility (%) of gram-positive bacteria
isolated from patients treated at the Burns Unit of Hospital
Regional da Asa Norte, Brasília, from June 2001 to May 2002.
Oxacillin Oxacillin Coagulase-
susceptible resistant negative
S. aureus S. aureus staphylococci
Antibiotic n= 16 n= 11 n= 12
Amoxicillin/
Clavulanic acid 87.5 0 50.0
Cephalothin 87.5 0 50.0
Cefuroxime ND 0 50.0
Imipenem 93.8 0 50.0
Oxacillin 100 0 50.0
Gentamicin 100 0 66.7
Amikacin 100 ND 66.7
Ciprofloxacin 100 27.3 83.3
Clindamycin 87.5 0 83.3
Co-trimoxazole 93.8 45.5 66.7
Vancomycin 100 100 100
ND = not done
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Twelve (24.5%) septicemic patients died during
the study period, with a mean age of 33 years (range
one to 89 years). Their burned body surface area
varied from 17 to 84% (mean 50%) and seven
Table 3 - Antimicrobial susceptibility (%) of gram-negative bacteria isolated from
patients treated at the Burns Unit of Hospital Regional da Asa Norte, Brasília, from
June 2001 to May 2002.
A. baumannii E. cloacae K. pneumoniae P.  aeruginosa
Antibiotic N = 7 N = 7 N = 5 N = 4
Ampicillin/Sulbactam 71.4 42.9 80.0 ND
Aztreonan ND 57.1 60.0 ND
Cephalothin 0 0 60.0 ND
Cefoxitin ND 0 ND ND
Ceftriaxone 0 ND ND 25.0
Ceftazidime 14.3 ND ND 50.0
Cefuroxime 0 ND ND 0
Ticarcillin/clavulanic acid 28.6 42.9 80.0 25.0
Piperacillin 14.3 42.9 20.0 0
Imipenem 85.7 100 100 100
Gentamicin 14.3 71.4 80.0 25.0
Amikacin 14.3 85.7 80.0 100
Ciprofloxacin 14.3 85.7 100 100
Co-trimoxazole ND 42.9 60.0 ND
ND = not  done
Table 4 - Clinical and laboratory findings of sepsis of the 49 patients
treated at the Burns Unit of Hospital Regional da Asa Norte, Brasília,













hemoglobin  < 10 g/dl 35 71.4
leukocytosis > 12,000 cells/ml 33 67.3
serum albumin  < 2.5 g/dl 24 49.0
thrombocytopenia < 100,000/ml 18 36.7
total  bilirubin  > 2 mg/dl 7 14.2
serum creatinine > 2 mg/dl 6 12.2
(58.3%) had over 50% burned body surface area.
There were 17 septic episodes among these 12
patients during their stay in the hospital until the
time of their deaths (Table 5).
DISCUSSION
Thermal injury is associated with anatomic,
physiologic, endocrinologic, and immunologic
alterations, which require specialized care. Cutaneous
injury results in significant fluid loss as well as the
release of multiple inflammatory mediators. When
disseminated by the circulation, bacteria and
inflammatory mediators can cause sepsis, and,
ultimately, multiple organ failure3.
The majority of septic episodes ocurred in the first
two weeks postburn, which confirms the earlier
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observation by Bang et al1. This early detection was
possible probably because of continuous observation
for the clinical signs of sepsis, regular inspection of
burn wounds for any change, and timely culture of
blood specimens.
The main source of sepsis in these groups of
patients was the burn wound. One reason for this might
have been the fact that multiresistant nosocomial
organisms present in the Burn Unit form the normal
flora of the burned patient within a few days of
admission, replacing the original endogenous flora.
However in the majority of septic episodes, the source
of sepsis was not identified. Our results are similar to
those of other authors1 13 19 22 26.
The flame burn was the predominant cause of burn
amongst patients who had sepsis due to the fact that
this agent produces deeper and more extensive lesions
than other agents, leading to more colonization of burn
wound and sepsis10 15 20 24.
The majority of septic episodes being due to
Staphylococcus might reflect the fact that Burns Units
are a major source of this bacteria, as confirmed by
other authors1 4 6 14 16. The incidence of oxacillin resistance
among Staphylococcus was high (40.7% for S. aureus
and 50% for coagulase-negative Staphylococcus).
Furthermore, coagulase negative Staphylococcus
should be considered an important pathogen for
sepsis in burns. The organism, being ubiquitous in a
hospital environment, and burn wounds being the ideal
medium for its multiplication, it is hardly surprising
that this bacteria would be the cause of 20.7% of
septic episodes. The possibility of contamination was
excluded by collecting specimens from different sites
with appropriate aseptic procedures as well as
repeated cultures of blood specimens and clinical
correlation.
The low incidence of Pseudomonas sepsis (only
6.9%) in burned patients indicates a decline of septic
episodes due to this organism as confirmed by other
authors5 8 11 18 21 25 27 . The reasons for this decline may be
effective topical and systemic antibiotics, as well as
the competition by other more adaptable bacteria. All
strains of P. aeruginosa were sensitive to imipenem,
amikacin and ciprofloxacin, although other workers have
demonstrated low susceptibility of P. aeruginosa to
aminoglycosides and to ciprofloxacin12 13 14 17 28.
Burn sepsis due to Acinetobacter deserves attention,
though this organism was rarely implicated in sepsis until
1970. However, this organism had been isolated more
frequently from blood cultures and is frequently multi-
resistant5 23 25. This bacteria was the third most common
organism isolated in our patients after S. aureus and
coagulase-negative Staphylococcus. More than 70% of
Acinetobacter baumannii isolated were susceptible only
to ampicillin/sulbactam and imipenem. The observation
made in this study that 12.1% of the septic episodes
were due to Acinetobacter baumannii is important because
its emergence might have been linked to the extensive
use of broad-spectrum antibiotics, resulting in its
classification as a nosocomial pathogen5 27 29.
Septicemia due to Candida sp is not uncommon in
burned patients and four patients in this study developed
sepsis due to this fungi. Most of these episodes were
associated with patients having burns of > 50% burned
total body surface area, prolonged hospital stay (> four
weeks), use of multiple antibiotics and delay in surgery
for the closure of the wounds8 18 26.
The lethality rate of 24.5% in septic patients was
lower compared to those reported in earlier studies.
The reduced mortality rate in these patients may
probably be attributed to adequate resuscitation
together with continuous clinical and microbiological
surveillance leading to quick detection of etiology,
institution of appropriate antibiotics, care over nutrition,
early excision and wound coverage.
The appropriate knowledge of clinical findings,
epidemiological, laboratorial and microbiological
aspects of sepsis in burned patients permits an
adequate diagnosis and treatment of this complication.
Table 5 - Details of the burned patients who died due to septicemia.
No. Age Burn No. septicemic Last-organism(s) Death Organ (s) affected
(years) (%) episodes detected postburn day in necropsy
1 29 50 2 Candida sp 49th lung
2 57 35 3 S. marcescens 9th lung
3 89 17 3 E. cloacae 22nd lung
4 37 84 1 A.  baumannii 9th heart, lung
5 1 70 1 P. aeruginosa, E. cloacae  8th **
6 24 19 1 A.. baumannii 15th lung
7 42 63 1 A.. baumannii 8th lung
8 29 72 1 E. coli, E. cloacae 5th lung, liver
9 20 42 1 S. aureus 13th lung, peritoneum
10 3 54 1 S. aureus 7th lung
11 17 50 1 E. cloacae 10th lung
12 46 40 1 CNS* 6th **
* CNS= coagulase-negative Staphylococcus. **  There was not any organ affected significantly in necropsy.
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